ABVC BioPharma, Inc. Realized Investment Gains (Losses)
ABVC BioPharma, Inc. (ABVC) reported Realized Investment Gains (Losses) of -$1.20 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2026-08-12
- ABVC BioPharma, Inc. realized investment gains (losses) for the quarter ending 2026-06-30 was -$36.00.
- ABVC BioPharma, Inc. realized investment gains (losses) for the quarter ending 2026-03-31 was -$1.17K.
- ABVC BioPharma, Inc. realized investment gains (losses) for the quarter ending 2020-12-31 was -$2.32K.
- ABVC BioPharma, Inc. realized investment gains (losses) for the quarter ending 2020-09-30 was $665.00.
- ABVC BioPharma, Inc. realized investment gains (losses) for fiscal 2022 was -$7.45K.
- ABVC BioPharma, Inc. realized investment gains (losses) for fiscal 2020 was -$40.59K.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$36.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$1.20K 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$1.17K 10-Q · filed 2026-05-18 | |||
| 2022-12-31 | -$7.45K 10-K · filed 2023-03-31 | |||
| 2020-12-31 | -$2.32K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$1.65K derived: sum of 2 quarters · filed 2022-03-31 | -$40.59K derived: sum of 3 quarters · filed 2022-03-31 | -$40.59K 10-K · filed 2022-03-31 |
| 2020-09-30 | $665.00 10-Q · filed 2021-11-15 | -$38.27K derived: sum of 2 quarters · filed 2021-11-15 | -$38.27K 10-Q · filed 2021-11-15 | |
| 2020-06-30 | -$38.94K 10-Q · filed 2021-08-12 | -$38.94K 10-Q · filed 2021-08-12 |